Invention Grant
- Patent Title: Inhibition of MAP4K4 through RNAI
- Patent Title (中): 通过RNAI抑制MAP4K4
-
Application No.: US13130194Application Date: 2009-11-19
-
Publication No.: US09074211B2Publication Date: 2015-07-07
- Inventor: Tod M. Woolf , Joanne Kamens , Anastasia Khvorova , William Salomon
- Applicant: Tod M. Woolf , Joanne Kamens , Anastasia Khvorova , William Salomon
- Applicant Address: US MA Marlborough
- Assignee: RXi Pharmaceuticals Corporation
- Current Assignee: RXi Pharmaceuticals Corporation
- Current Assignee Address: US MA Marlborough
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2009/006211 WO 20091119
- International Announcement: WO2010/059226 WO 20100527
- Main IPC: C12N15/113
- IPC: C12N15/113

Abstract:
RNAi constructs directed to MAP4K4 that demonstrate unexpectedly high gene silencing activities, and uses thereof are disclosed. The blunt-ended constructs have a double-stranded region of 19-49 nucleotides. The constructs have selective minimal modifications to confer an optimal balance of biological activity, toxicity, stability, and target gene specificity. For example, the strands may be modified (e.g., one or both ends of the sense strand is modified by 2′-O-methyl groups), such that the construct is not cleaved by Dicer or other RNAse III, the antisense strand may also be modified by a 2′-O-methyl group at the penultimate 5′-end nucleotide to greatly reduce off-target silencing.
Public/Granted literature
- US20120059046A1 INHIBITION OF MAP4K4 THROUGH RNAI Public/Granted day:2012-03-08
Information query
IPC分类: